Cann Pharmaceutical (to be renamed better™ Pharmaceutical Australia) is a part of the better™ Holdings group headquartered in Israel.
To build on the 10 years of better's licensed production of pharma-grade medicinal cannabis treatments that supply over 12,000 patients in Israel.
To produce licensed cannabinoid medicines in Australia that address 16 unmet medical conditions.
We aim to provide physicians with trialled product data and solutions for patients.
Our global vision: Global medicine, Same quality, One medical brand - better™
Healthcare professionals and patients considering cannabinoid-based treatments will encounter terms such as "phytocannabinoids" and "endocannabinoids".
Endocannabinoids are cannabinoids synthesised in our bodies, while phytocannabinoids are the cannabinoids derived from the cannabis plant. They are produced inside glandular trichomes, mainly found on the female flowering heads. The pharmacological and medicinal properties of cannabis are largely due to the interaction of these phytocannabinoids with receptors in our bodies.